1223 related articles for article (PubMed ID: 23744124)
21. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
[TBL] [Abstract][Full Text] [Related]
22. Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia.
Calfa CJ; Lossos IS; Ruiz P; Davis JL
Am J Ophthalmol; 2007 Aug; 144(2):326-9. PubMed ID: 17659976
[TBL] [Abstract][Full Text] [Related]
23. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
[TBL] [Abstract][Full Text] [Related]
24. Primary Vitreoretinal Lymphoma Presenting as a Posterior Capsule Plaque.
Hussain RM; Garoon RB; Duker JS; Dubovy SR; Albini TA
Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):732-734. PubMed ID: 30222812
[TBL] [Abstract][Full Text] [Related]
25. Two types of initial ocular manifestations in intraocular-central nervous system lymphoma.
Matsuo T; Yamaoka A; Shiraga F; Matsuo N
Retina; 1998; 18(4):301-7. PubMed ID: 9730171
[TBL] [Abstract][Full Text] [Related]
26. [Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center].
Joubert R; Bonnin N; Kemeny JL; Moluçon-Chabrot C; Tournilhac O; Bacin F; Chiambaretta F
J Fr Ophtalmol; 2015 Jun; 38(6):559-66. PubMed ID: 25976140
[TBL] [Abstract][Full Text] [Related]
27. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
28. Ocular lymphoma in a patient with chronic lymphocytic leukemia.
Hattenhauer MG; Pach JM
Am J Ophthalmol; 1996 Aug; 122(2):266-8. PubMed ID: 8694099
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous diffuse large B-cell lymphoma with intraocular involvement.
Chi M; Bucher N; Gabrielian A; MacCumber MW; Zdunek T
Future Oncol; 2012 Jun; 8(6):757-60. PubMed ID: 22764772
[TBL] [Abstract][Full Text] [Related]
30. Diffuse large B-cell lymphoma of the orbit: clinicopathologic, immunohistochemical, and prognostic features of 20 cases.
Stacy RC; Jakobiec FA; Herwig MC; Schoenfield L; Singh A; Grossniklaus HE
Am J Ophthalmol; 2012 Jul; 154(1):87-98.e1. PubMed ID: 22503694
[TBL] [Abstract][Full Text] [Related]
31. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Delhiwala K
Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
[TBL] [Abstract][Full Text] [Related]
32. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases.
Plaza JA; Kacerovska D; Sangueza M; Schieke S; Buonaccorsi N; Suster S; Kazakov DV
Am J Dermatopathol; 2014 Jun; 36(6):478-82. PubMed ID: 24698933
[TBL] [Abstract][Full Text] [Related]
33. Concurrent primary vitreoretinal and spinal cord lymphoma: a unique entity.
Ezon IC; Barteselli G; Rosenberg J; Freeman WR
JAMA Ophthalmol; 2014 Jul; 132(7):902-4. PubMed ID: 25010176
[No Abstract] [Full Text] [Related]
34. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.
Abu Samra K; Oray M; Ebrahimiadib N; Lee S; Anesi S; Foster CS
Ocul Immunol Inflamm; 2018; 26(3):347-352. PubMed ID: 27438792
[TBL] [Abstract][Full Text] [Related]
35. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
36. How we diagnose and treat vitreoretinal lymphoma.
Fend F; Ferreri AJ; Coupland SE
Br J Haematol; 2016 Jun; 173(5):680-92. PubMed ID: 27133587
[TBL] [Abstract][Full Text] [Related]
37. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
38. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
Ahmed AH; Foster CS; Shields CL
JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
[TBL] [Abstract][Full Text] [Related]
39. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
[TBL] [Abstract][Full Text] [Related]
40. Contribution of vitreous cytology to final clinical diagnosis fifteen-year review of vitreous cytology specimens from one institution.
Wittenberg LA; Maberley DA; Ma PE; Wade NK; Gill H; White VA
Ophthalmology; 2008 Nov; 115(11):1944-50. PubMed ID: 18672292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
